Andrews Patricia S — SEC Form 4 filings

SEC reporting owner CIK 1445710. 4 Form 4 filings on record with FilingPulse; latest filed 2026-06-03.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-05-01 to 2026-06-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ONCOLYTICS BIOTECH INC (ONCY)Director21 leg · 35,400 sh · $30,2921
GERON CORP (GERN)Director11
GLYCOMIMETICS INC (GLYC)Director11

Form 4 filings — Andrews Patricia S

FiledFormIssuerReported transactionsSource
2026-06-034ONCOLYTICS BIOTECH INC (ONCY)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2026-03-264GERON CORP (GERN)Grant/award (A): 270,000 (derivative) @ $0EDGAR
2026-02-134ONCOLYTICS BIOTECH INC (ONCY)Purchase (P): 35,400 @ $0.86EDGAR
2024-05-014GLYCOMIMETICS INC (GLYC)Grant/award (A): 40,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1445710 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →